1-20 of 43
Keywords: Diabetic nephropathy
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Nephron Experimental Nephrology (2014) 128 (1-2): 46–56.
Published Online: 05 November 2014
...Yonggui Wu; Yan Wang; Xiangming Qi; Pei Zhang; Chaoqun Zhang; Wei Zhang Background/Aims: Accumulating evidence suggests that macrophage-induced inflammation may be the mechanism of development and progression of diabetic nephropathy. A previous study by our group has shown that tacrolimus, like...
Journal Articles
Nephron Experimental Nephrology (2014) 126 (4): 191–195.
Published Online: 12 July 2014
...Boris Betz; Bryan R. Conway Diabetic nephropathy (DN) is the single most common cause of end-stage kidney disease. Therefore, it is imperative that novel therapies are developed. Progress has been hindered, however, by the lack of robust animal models. In the current review we describe recent...
Journal Articles
Nephron Experimental Nephrology (2014) 126 (3): 148–156.
Published Online: 16 May 2014
...Hua Jin; Shang Guo Piao; Ji Zhe Jin; Ying Shun Jin; Zhen Hua Cui; Hai Feng Jin; Hai Lan Zheng; Jin Ji Li; Yu Ji Jiang; Chul Woo Yang; Can Li Background: Leflunomide (LEF) and benazepril have renoprotective effects on diabetic nephropathy (DN) through their anti-inflammatory and anti-fibrotic...
Journal Articles
Nephron Experimental Nephrology (2014) 126 (1): 16–24.
Published Online: 28 February 2014
... as appropriate. p < 0.05 was considered significant. 22 04 2013 14 01 2014 28 02 2014 Diabetic nephropathy Inflammatory cytokines Mineralocorticoid receptor Obesity Rac1 The prevalence of end-stage renal disease is rapidly increasing worldwide, and this increment...
Journal Articles
Journal Articles
Nephron Experimental Nephrology (2012) 122 (1-2): 36–50.
Published Online: 14 March 2013
...S.N. Verouti; E.C. Tsilibary; E. Fragopoulou; C. Iatrou; C.A. Demopoulos; A.S. Charonis; S.A. Charonis; G.I. Drossopoulou Background: Vitamin D is beneficial in human and experimental chronic kidney disease, the leading cause of which is diabetic nephropathy. Vitamin D through its receptor, VDR...
Journal Articles
Nephron Experimental Nephrology (2012) 121 (3-4): e97–e108.
Published Online: 10 January 2013
... diabetic nephropathy, because of its renoprotective effects. However, the mechanism by which telmisartan prevents proteinuria and renal dysfunction in diabetic nephropathy is still unclear. In this study, we examined the effects of telmisartan against diabetic nephropathy in db/db mice. Methods...
Journal Articles
Nephron Experimental Nephrology (2012) 121 (3-4): e109–e121.
Published Online: 09 January 2013
... topic of research. Recent evidence indicates that hyperuricemia is associated with increased TGF-β 1 and progressive tubulointerstitial injury. We examined the hypothesis that lowering serum uric acid attenuates TGF-β 1 -induced profibrogenic tubular change in type 2 diabetic nephropathy. Methods: KK...
Journal Articles
Nephron Experimental Nephrology (2012) 120 (2): e81–e90.
Published Online: 28 April 2012
.... 2012 Tempol Poly(ADP-ribose) polymerase Diabetic nephropathy Albuminuria Oxidative stress Apoptosis Podocyte Podocytes or glomerular visceral epithelial cells are important components of the integrity of the glomerular filtration barrier [ 1, 2, 3 ]. It has been demonstrated...
Journal Articles
Nephron Experimental Nephrology (2011) 119 (1): e21–e32.
Published Online: 09 June 2011
...Shirong Zheng; Yun Huang; Lu Yang; Teresa Chen; Jianxiang Xu; Paul N. Epstein Background/Aims: OVE26 (OVE) mice provide a valuable model of advanced diabetic nephropathy (DN), but they take 8 months to develop moderate interstitial fibrosis and reduced glomerular filtration rate (GFR). The aim...
Journal Articles
Nephron Experimental Nephrology (2011) 119 (1): e8–e20.
Published Online: 23 May 2011
... to be markers of human advanced diabetic nephropathy and the NF-ĸB_IFN_x promoter module were elevated in the oldest diabetic mice. Vitamin D inhibits diabetic renal inflammation. Vitamin D and mRNA for vitamin D synthetic enzyme CYP2B1 were elevated in kidneys of young OVE26 mice. Conclusions: OVE26 mice...
Journal Articles
Nephron Experimental Nephrology (2011) 118 (4): e87–e99.
Published Online: 11 February 2011
... macrophages in other renal diseases such as diabetic nephropathy remains unknown. Methods: Macrophages were separated from splenocytes and polarized with IL-4 and IL-13 into a protective phenotype. Mice underwent adoptive transfer with M2 macrophages, and then diabetes was induced by tail vein injection...
Journal Articles
Nephron Experimental Nephrology (2011) 118 (3): e49–e59.
Published Online: 11 January 2011
...Lynetta M. Phillips; Ying Wang; Tiane Dai; David L. Feldman; Janine LaPage; Sharon G. Adler Background/Aims: Altered extracellular matrix (ECM) remodeling and podocyte apoptosis are characteristic features of diabetic nephropathy (DN). Aliskiren (ALI) inhibits the renin-catalyzed conversion...
Journal Articles
Journal Articles
Nephron Experimental Nephrology (2011) 117 (1): e21–e30.
Published Online: 04 August 2010
...Christiane Ruester; Sybille Franke; Tzvetanka Bondeva; Gunter Wolf Background: Podocyte damage and accumulation of advanced glycation end-products (AGEs) are implicated in the development and progression of diabetic nephropathy. We have previously shown that changes in podocyte pathophysiology...
Journal Articles
Nephron Experimental Nephrology (2010) 116 (1): e11–e21.
Published Online: 21 May 2010
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2010 Decorin Transforming growth factor &#946;1 Smad Albuminuria Diabetic nephropathy Diabetic nephropathy (DN) is a major long-term complication...
Journal Articles
Subject Area:
Nephrology
Nephron Experimental Nephrology (2009) 113 (2): e66–e76.
Published Online: 16 July 2009
...) has a protective effect on lipid peroxidation. Adiponectin and AMPK might have a role in the pathogenesis of diabetic nephropathy. Blockade of the renin-angiotensin system (RAS) increases adiponectin levels and reduces oxidative stress. The objective of the present study was to examine lipid...
Journal Articles
Subject Area:
Nephrology
Nephron Experimental Nephrology (2009) 113 (1): e8–e15.
Published Online: 09 July 2009
... from any ideas, methods, instructions or products referred to in the content or advertisements. 2009 Vascular endothelial growth factor Glomerular endothelial cells Glomerulopathy Diabetic nephropathy Pre-eclampsia Hypertension The glomerulus forms the filtering component of each...
Journal Articles
Subject Area:
Nephrology
Nephron Experimental Nephrology (2009) 111 (2): e31–e41.
Published Online: 13 January 2009
...Xianhua Li; Yunling Xiao; Haiqing Gao; Baoying Li; Ling Xu; Mei Cheng; Bei Jiang; Yabing Ma Background: Diabetic nephropathy (DN) is the most common cause of end-stage renal failure. Grape seed proanthocyanidin extracts (GSPE) are powerful antioxidants. However, the role of GSPE on advanced...
Journal Articles
Subject Area:
Nephrology
Nephron Experimental Nephrology (2009) 111 (1): e11–e19.
Published Online: 02 December 2008
...David W. Powell; Clinton C. Bertram; Timothy D. Cummins; Michelle T. Barati; Shirong Zheng; Paul N. Epstein; Jon B. Klein Background/Aims: Tubulointerstitial fibrosis (TIF) is a prominent feature of progressive diabetic nephropathy. The goal of this study was to determine if hallmarks of TIF occur...